BrettMD
Saturday, December 27, 2014
RT @NovartisCancrUS: Please share! #NCT01857193 is a Phase Ib/II trial studying #BreastCancer #HER2-. More info: http://t.co/affV1bhYth
RT @NovartisCancrUS: Please share! #NCT01857193 is a Phase Ib/II trial studying #BreastCancer #HER2-. More info: http://t.co/affV1bhYth (via Twitter http://twitter.com/BrettSnodgrass1/status/549044839119978497)
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment